Baxter International Inc. (BAX)

36,55 +0,47 (+1,30 %) À la clôture : 04:00PM EST

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000
https://www.baxter.com

Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 60 000

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Jose E. Almeida	Chairman of the Board, President & CEO	2,1M	S.O.	1962
Mr. David S. Rosenbloom	Executive VP & General Counsel	776,51k	S.O.	1960
Mr. Joel T. Grade	Executive VP & CFO	S.O.	S.O.	1971
Mr. Talvis P. Love	Senior VP & Chief Information Officer	S.O.	S.O.	1968
Ms. Tobi Karchmer M.D., M.S.	Senior VP and Chief Medical & Scientific Officer	S.O.	S.O.	S.O.
Ms. Clare Trachtman	Vice President of Investor Relations	S.O.	S.O.	S.O.
Ms. Stacey Eisen	Senior Vice President of Global Communications	S.O.	S.O.	S.O.
Ms. Jeanne K. Mason Ph.D.	?Executive VP & Chief Human Resources Officer	1,99M	S.O.	1956
Mr. James W. Borzi	Executive VP & Chief Supply Chain Officer	S.O.	S.O.	1963
Ms. Heather Knight	Executive VP & Group President of Medical Products and Therapies	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Baxter International Inc. en date du 1 décembre 2023 est 6. Les scores principaux sont Audit : 6; Société : 6; Droits des actionnaires : 1; Compensation : 9.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.